We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Teladoc (TDOC) Up 17% Since Earnings Report: Can It Continue?
Read MoreHide Full Article
It has been about a month since the last earnings report for Teladoc, Inc. (TDOC - Free Report) . Shares have added about 17% in that time frame, outperforming the market.
Will the recent positive trend continue leading up to the stock's next earnings release, or is it due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers.
Teladoc Q1 Loss Lower Than Expected, ’17 View Intact
Teladoc Inc.’s first-quarter 2017 operating loss of $0.30 per share came in narrower than the Zacks Consensus Estimate of a loss of $0.33 per share. In the year-ago quarter, the company had incurred a loss of $0.40 per share.
Total revenue during the quarter came in at $42.9 million, above the Zacks Consensus Estimate of $42 million and up 60% year over year. Revenues were above the high end of the company’s guided range of $41.5–$42.5 million.
Revenue from subscription access fees and visit fees was $34.3 million and $8.6 million, respectively, reflecting an increase of 66% and 39% year over year. The increase in subscription fees reflects overall membership expansion and contributions from HealthiestYou.
Total operating expenses were $45.6 million, 51% higher year over year. The increase was due to increased expenditure on advertising, marketing and sales.
Adjusted EBITDA narrowed to a loss of $9.1 million from a loss of $11.9 million, in the year-ago quarter, and came in better than the company’s guided range of a loss of $10 million to $11 million.
Total visits of 384,839 surged 60% year over year. Total visits came within the company’s guided range of 375,000 to 385,000.
Total membership was 20.1 million, reflecting an increase of 34% year over year. It also came within the company’s guided range of 20 million to 20.5 million.
Financial Position
Teldoc’s total assets were approximately $414 million as of Mar 31, 2017, up from $303.7 million as of Dec 31, 2016. Total cash, cash equivalents and marketable securities were $36 million as of Mar 31, 2017, up from $15.8 million as of Dec 31, 2016.
Guidance
For the second quarter of 2017, the company currently expects total revenue between $44 million and $45 million, EBITDA loss between $10.5 million and $11.5 million and adjusted EBITDA loss between $6 million and $7 million. Teladoc also projects total membership of approximately 20 million to 21.5 million, total visits between 290,000 and 310,000 and net loss per share based on 54.5 million weighted average shares outstanding of $0.26 to $0.28 per share.
The company reiterated its full-year 2017 guidance provided during the fourth-quarter earnings release. It continues to expect total revenue between $180 million and $185 million, EBITDA loss between $31 million and $34 million and adjusted EBITDA loss between $19.5 million and $22.5 million. The company targets adjusted EBITDA of a break-even in the fourth quarter of this year and total membership of approximately 21.5 million to 23 million. Total visits between 1.4 million and 1.45 million and net loss per share based on 54.2 million weighted average shares outstanding of $0.85 to $0.91 per share are expected for.full year 2017.
How Have Estimates Been Moving Since Then?
Analysts were quiet during the last one month period as none of them issued any earnings estimate revisions.
VGM Scores
At this time, the stock has a subpar Growth Score of 'D', a grade with the same score on the momentum front. Following the exact same course, the stock was allocated also a grade of 'F' on the value side, putting it in the fifth quintile for this investment strategy.
Overall, the stock has an aggregate VGM Score of 'F'. If you aren't focused on one strategy, this score is the one you should be interested in.
Our style scores indicate investors will probably be better served looking elsewhere.
Outlook
The stock has a Zacks Rank #3 (Hold). We are expecting an inline return from the stock in the next few months.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Teladoc (TDOC) Up 17% Since Earnings Report: Can It Continue?
It has been about a month since the last earnings report for Teladoc, Inc. (TDOC - Free Report) . Shares have added about 17% in that time frame, outperforming the market.
Will the recent positive trend continue leading up to the stock's next earnings release, or is it due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers.
Teladoc Q1 Loss Lower Than Expected, ’17 View Intact
Teladoc Inc.’s first-quarter 2017 operating loss of $0.30 per share came in narrower than the Zacks Consensus Estimate of a loss of $0.33 per share. In the year-ago quarter, the company had incurred a loss of $0.40 per share.
Total revenue during the quarter came in at $42.9 million, above the Zacks Consensus Estimate of $42 million and up 60% year over year. Revenues were above the high end of the company’s guided range of $41.5–$42.5 million.
Revenue from subscription access fees and visit fees was $34.3 million and $8.6 million, respectively, reflecting an increase of 66% and 39% year over year. The increase in subscription fees reflects overall membership expansion and contributions from HealthiestYou.
Total operating expenses were $45.6 million, 51% higher year over year. The increase was due to increased expenditure on advertising, marketing and sales.
Adjusted EBITDA narrowed to a loss of $9.1 million from a loss of $11.9 million, in the year-ago quarter, and came in better than the company’s guided range of a loss of $10 million to $11 million.
Total visits of 384,839 surged 60% year over year. Total visits came within the company’s guided range of 375,000 to 385,000.
Total membership was 20.1 million, reflecting an increase of 34% year over year. It also came within the company’s guided range of 20 million to 20.5 million.
Financial Position
Teldoc’s total assets were approximately $414 million as of Mar 31, 2017, up from $303.7 million as of Dec 31, 2016.
Total cash, cash equivalents and marketable securities were $36 million as of Mar 31, 2017, up from $15.8 million as of Dec 31, 2016.
Guidance
For the second quarter of 2017, the company currently expects total revenue between $44 million and $45 million, EBITDA loss between $10.5 million and $11.5 million and adjusted EBITDA loss between $6 million and $7 million. Teladoc also projects total membership of approximately 20 million to 21.5 million, total visits between 290,000 and 310,000 and net loss per share based on 54.5 million weighted average shares outstanding of $0.26 to $0.28 per share.
The company reiterated its full-year 2017 guidance provided during the fourth-quarter earnings release. It continues to expect total revenue between $180 million and $185 million, EBITDA loss between $31 million and $34 million and adjusted EBITDA loss between $19.5 million and $22.5 million. The company targets adjusted EBITDA of a break-even in the fourth quarter of this year and total membership of approximately 21.5 million to 23 million. Total visits between 1.4 million and 1.45 million and net loss per share based on 54.2 million weighted average shares outstanding of $0.85 to $0.91 per share are expected for.full year 2017.
How Have Estimates Been Moving Since Then?
Analysts were quiet during the last one month period as none of them issued any earnings estimate revisions.
VGM Scores
At this time, the stock has a subpar Growth Score of 'D', a grade with the same score on the momentum front. Following the exact same course, the stock was allocated also a grade of 'F' on the value side, putting it in the fifth quintile for this investment strategy.
Overall, the stock has an aggregate VGM Score of 'F'. If you aren't focused on one strategy, this score is the one you should be interested in.
Our style scores indicate investors will probably be better served looking elsewhere.
Outlook
The stock has a Zacks Rank #3 (Hold). We are expecting an inline return from the stock in the next few months.